These are just some of the news headlines that have seen the world cancer vaccine market turned on its head. The benefits are unquestionable, the costs of the drugs however may yet see take-up slow.
May 1, 2007 (Press Release) --
These are just some of the news headlines that have seen the world cancer vaccine market turned on its head. The benefits are unquestionable, the costs of the drugs however may yet see take-up slow. How will this effect your company? This report will tell you.
There are two types of cancer vaccines :
Prophylactic cancer vaccines, designed to prevent the development of cancer, they are given to healthy subjects to prevent infection with cancer-causing viruses
Therapeutic cancer vaccines, designed to treat existing cancers, they are given to cancer patients to stimulate the immune system into recognizing and destroying their existing cancer
Previously the cancer vaccine market has consisted of HBV (hepatitis B virus) vaccines to prevent liver cancer. 2006 saw the launch of Gardasil the first vaccine against HPV (human papilloma virus) to protect against cervical cancer. Another HPV vaccine, Cervarix, is due to be launched in 2007. These two vaccines are together predicted to generate sales of more than $4bn in 2012, which could see them becoming the top selling vaccines. Their success could lead a growth in the cancer vaccines market, resulting in it being worth 7 times what it is today. Will you be able to capture your share of the market place?
Therapeutic cancer vaccines, designed to stimulate the immune system into killing existing cancers, also look likely to soon achieve commercial success, after much investment into their research and development. The first therapeutic cancer vaccine is expected to be launched in 2007, with a number of others predicted to obtain licenses in the next few years. Hw will this effect current cancer drugs and treatments? Understand today.
The report gives an overview of the current and potential market for cancer vaccines, in particular concentrating on the following aspects of cancer vaccines :
Technologies utilised by cancer vaccines
Key players in cancer vaccines
Revenue forecasts for prophylactic cancer vaccines
Therapeutic cancer vaccines likely to achieve commercial success
Drivers and opportunities in the cancer vaccine market
Restraints and threats in the cancer vaccine market
The cancer vaccine pipeline
Why you must by this report:
The pharmaceutical industry has been seeking the next blockbuster drug, yet it appears as though these might not be as profligate as they have been in the past. However, the addiction treatment markets hold promise, particularly for the development of products for nicotine addiction and the treatment of obesity. This report analyses the current situation in the market and assesses the potential of the products that are currently in the development pipeline. A comprehensive analysis of the addiction treatment market from 2006-2011 outlines the potential of the market.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=40522
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +9
There are two types of cancer vaccines :
Prophylactic cancer vaccines, designed to prevent the development of cancer, they are given to healthy subjects to prevent infection with cancer-causing viruses
Therapeutic cancer vaccines, designed to treat existing cancers, they are given to cancer patients to stimulate the immune system into recognizing and destroying their existing cancer
Previously the cancer vaccine market has consisted of HBV (hepatitis B virus) vaccines to prevent liver cancer. 2006 saw the launch of Gardasil the first vaccine against HPV (human papilloma virus) to protect against cervical cancer. Another HPV vaccine, Cervarix, is due to be launched in 2007. These two vaccines are together predicted to generate sales of more than $4bn in 2012, which could see them becoming the top selling vaccines. Their success could lead a growth in the cancer vaccines market, resulting in it being worth 7 times what it is today. Will you be able to capture your share of the market place?
Therapeutic cancer vaccines, designed to stimulate the immune system into killing existing cancers, also look likely to soon achieve commercial success, after much investment into their research and development. The first therapeutic cancer vaccine is expected to be launched in 2007, with a number of others predicted to obtain licenses in the next few years. Hw will this effect current cancer drugs and treatments? Understand today.
The report gives an overview of the current and potential market for cancer vaccines, in particular concentrating on the following aspects of cancer vaccines :
Technologies utilised by cancer vaccines
Key players in cancer vaccines
Revenue forecasts for prophylactic cancer vaccines
Therapeutic cancer vaccines likely to achieve commercial success
Drivers and opportunities in the cancer vaccine market
Restraints and threats in the cancer vaccine market
The cancer vaccine pipeline
Why you must by this report:
The pharmaceutical industry has been seeking the next blockbuster drug, yet it appears as though these might not be as profligate as they have been in the past. However, the addiction treatment markets hold promise, particularly for the development of products for nicotine addiction and the treatment of obesity. This report analyses the current situation in the market and assesses the potential of the products that are currently in the development pipeline. A comprehensive analysis of the addiction treatment market from 2006-2011 outlines the potential of the market.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=40522
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +9
Email
Print
SPAM
